Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Finke

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Bioorganic & Medicinal Chemistry Letters|November 27, 2001
Design, synthesis, and SAR of heterocycle-containing antagonists of the human CCR5 receptor for the treatment of HIV-1 infectionD Kim, L Wang, C G Caldwell, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2001
Discovery of human CCR5 antagonists containing hydantoins for the treatment of HIV-1 infectionD Kim, L Wang, C G Caldwell, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2006
Cyclopentane-based human NK1 antagonists. Part 2: development of potent, orally active, water-soluble derivativesLaura C Meurer, Paul E Finke, Karen A Owens, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2001
Antagonists of the human CCR5 receptor as anti-HIV-1 agents. part 1: discovery and initial structure-activity relationships for 1 -amino-2-phenyl-4-(piperidin-1-yl)butanesC P Dorn, P E Finke, B Oates, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Syntheses and biological evaluation of 5-(piperidin-1-yl)-3-phenyl-pentylsulfones as CCR5 antagonistsK Shankaran, Karla L Donnelly, Shrenik K Shah, et al.
Organic Letters|July 5, 2003
CCR5 antagonists: 3-(pyrrolidin-1-yl)propionic acid analogues with potent anti-HIV activityChristopher L Lynch, Jeffrey J Hale, Richard J Budhu, et al.
European Journal of Pharmacology|November 21, 2007
Characterization of a novel and selective cannabinoid CB1 receptor inverse agonist, Imidazole 24b, in rodentsLauren P Shearman, D Sloan Stribling, Ramon E Camacho, et al.
Journal of Medicinal Chemistry|March 29, 2000
Phosphorylated morpholine acetal human neurokinin-1 receptor antagonists as water-soluble prodrugsJ J Hale, S G Mills, M MacCoss, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Bioorganic & Medicinal Chemistry Letters|November 27, 2001
Design, synthesis, and SAR of heterocycle-containing antagonists of the human CCR5 receptor for the treatment of HIV-1 infectionD Kim, L Wang, C G Caldwell, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2001
Discovery of human CCR5 antagonists containing hydantoins for the treatment of HIV-1 infectionD Kim, L Wang, C G Caldwell, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2006
Cyclopentane-based human NK1 antagonists. Part 2: development of potent, orally active, water-soluble derivativesLaura C Meurer, Paul E Finke, Karen A Owens, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2001
Antagonists of the human CCR5 receptor as anti-HIV-1 agents. part 1: discovery and initial structure-activity relationships for 1 -amino-2-phenyl-4-(piperidin-1-yl)butanesC P Dorn, P E Finke, B Oates, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Syntheses and biological evaluation of 5-(piperidin-1-yl)-3-phenyl-pentylsulfones as CCR5 antagonistsK Shankaran, Karla L Donnelly, Shrenik K Shah, et al.
Organic Letters|July 5, 2003
CCR5 antagonists: 3-(pyrrolidin-1-yl)propionic acid analogues with potent anti-HIV activityChristopher L Lynch, Jeffrey J Hale, Richard J Budhu, et al.
European Journal of Pharmacology|November 21, 2007
Characterization of a novel and selective cannabinoid CB1 receptor inverse agonist, Imidazole 24b, in rodentsLauren P Shearman, D Sloan Stribling, Ramon E Camacho, et al.
Journal of Medicinal Chemistry|March 29, 2000
Phosphorylated morpholine acetal human neurokinin-1 receptor antagonists as water-soluble prodrugsJ J Hale, S G Mills, M MacCoss, et al.
Pageof 7